With over 20 years’ experience in the pharmaceutical industry, Heather’s experience spans various markets, therapeutic areas and payer archetypes.

She is presently the Vice President of Market Access and Pricing for AstraZeneca Canada. Working in an HTA-driven market such as Canada, Heather’s team must be at the forefront of health economics, access strategy, pricing, payer negotiations and payer relations to optimize patient access to AstraZeneca’s products country-wide.

Prior to joining AstraZeneca, Heather was the Global VP of Market Access for Bayer Pharmaceuticals’ Cell and Gene Therapies + Digital Health portfolios, where her team was responsible for working with healthcare systems worldwide to develop innovative market access solutions for the company’s transformative therapies of the future.

Heather’s academic training includes pharmacology, epidemiology, statistics and research methodology, culminating in a PhD in Health Economics and Policy from McMaster University. Heather has published in a variety peer-reviewed journals and currently resides in Toronto, Canada.